Individualized Oncology at the Hallwang Clinic

Precise diagnostics, personalized treatment planning, and a patient-centered environment in the tranquil setting of the Black Forest.

The Hallwang Private Oncology Clinic is located in the peaceful landscape of Germany’s Northern Black Forest. The facility includes 16 patient rooms, two suites, and several adjoining apartments. Its intimate size enables close medical supervision and continuous coordination within the treatment team. Many patients arrive at the clinic after undergoing multiple prior therapies — often with the goal of reevaluating their treatment landscape and exploring new therapeutic opportunities.

The Hallwang Clinic offers a unique advantage for patients from countries with more restrictive healthcare systems — such as the United States, the United Kingdom, or Canada. Here, they gain access to state-of-the-art oncology therapies under German medical regulations — combined with individualized, holistic care in a private setting.

Personalized Treatment Planning Based on Precision Medicine

Tumor progression varies greatly between patients. Effective treatment must therefore consider both the molecular characteristics of the tumor and the patient’s medical history. The Hallwang Clinic operates on the principle of precision-based medicine — tailoring each therapy to the tumor’s individual biological profile and relevant clinical factors.

At the core is a scientifically grounded treatment plan that integrates medical evidence, molecular findings, and the patient’s current clinical context. The Hallwang Clinic’s medical expertise aligns with the latest international oncology guidelines — including those followed at centers like Memorial Sloan Kettering and MD Anderson.

Molecular and Functional Diagnostics as the Foundation

Therapy planning at the Hallwang Clinic begins with a comprehensive diagnostic process — analyzing tumor tissue and blood samples to reveal actionable biological features:

Genomic profiling identifies genetic mutations and signaling pathways that drive tumor growth. Tumor antigen and immunological profiling helps assess whether immunotherapy is likely to be effective. DNA repair analysis and tumor mutational burden (TMB) testing provide insight into the potential efficacy of targeted or immune-modulating therapies.

In addition, liquid biopsy methods are available — enabling the detection of circulating tumor components via blood samples. This allows clinicians to monitor disease progression, treatment response, and resistance mechanisms without the need for repeated biopsies. In select cases, chemosensitivity testing is performed on isolated tumor cells to further guide drug selection.

These diagnostic tools form the core of precision oncology — providing the foundation for evidence-based, targeted treatment strategies.

Therapeutic Options Including Off-Label Treatments

Based on diagnostic findings, the Hallwang treatment team makes individualized therapy decisions. These may include targeted therapies that block specific signaling pathways or structural abnormalities in tumor cells — combined with innovative immunotherapeutic approaches that enhance the body’s ability to detect and control cancer.

Therapies include checkpoint inhibitors, immune priming concepts, antibody-drug conjugates, and — in carefully selected cases — cellular therapies such as CAR-T cells. Treatment decisions are guided by molecular findings, disease dynamics, and the patient’s overall condition.

When diagnostics reveal a clear therapeutic target and scientifically supported rationale, the clinic may also apply evidence-based off-label therapies — a practice permitted under German law. Each decision is made through a structured, interdisciplinary, and transparently documented process.

​​Interdisciplinary Medical Team

The Hallwang Private Oncology Clinic’s team includes oncologists, internists, specialized oncology nurses, psychologists, and additional therapeutic professionals. Our physicians bring scientific experience from world-leading cancer centers, including:

• Dana-Farber Cancer Institute, Harvard Medical School, Boston
• Sidney Kimmel Comprehensive Cancer Center, Johns Hopkins Hospital, Baltimore
• Walter and Eliza Hall Institute, Melbourne
• Center for Integrated Oncology Cologne/Bonn

As well as other academic research networks

Our team maintains active memberships in organizations such as the European Society for Medical Oncology (ESMO) and the German Society for Hematology and Medical Oncology (DGHO).

The Hallwang Clinic emphasizes the physician–patient relationship as a key element of care. All diagnostics, treatment decisions, and therapy adjustments are discussed transparently and collaboratively.

Treatment and Care in Harmony

The Hallwang Clinic combines high-performance medical care with human connection. The clinical setting is quiet and intimate. Families are encouraged to participate. Communication remains open, clear, and compassionate. Beyond medical care, the clinic also focuses on nutrition, psychosocial support, and strategies to reduce physical and emotional strain.

The Hallwang Clinic doesn’t just treat the disease — it strengthens the patient’s capacity to cope with the journey. This fusion of precision-based medicine and compassionate care is what draws people from around the world to our clinic.